Lilley & Co’s Colgate-Palmolive CL Stock Holding History

Lilley & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,816	Closed	-$218K	–	104
2013 Q2	$218K	Buy	+3,816	New	+$227K	0.12%	91

Other funds holding CL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lilley & Co's CL Position: Q3 2013 in Review

Lilley & Co sold out of Colgate-Palmolive (CL) in Q3 2013, closing a stake of 3,816 shares — an estimated $218K sold.

Lilley & Co first reported a position in CL in Q2 2013 and held it in 1 quarter. The position peaked at $218K in Q2 2013. 1,091 funds tracked by Wall St. Rank hold CL as of Q3 2013.

Lilley & Co reported no remaining Colgate-Palmolive position as of Q3 2013 after selling out during the quarter.
Lilley & Co sold 3,816 Colgate-Palmolive shares in Q3 2013, an estimated $218K.
Lilley & Co first reported a position in Colgate-Palmolive in Q2 2013 and held it in 1 quarter.
Lilley & Co's Colgate-Palmolive position peaked at $218K in Q2 2013.
1,091 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2013.

Based on Lilley & Co's 13F filing for Q3 2013, filed 8 Nov 2013.